-

Fierce Healthcare Names Atropos Health a “Fierce 15” Company of 2026

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence (RWE), today announced that Fierce Healthcare has named it as one of 2026’s “Fierce 15” healthcare companies. The annual special report features the most innovative private healthcare companies looking to change the face of the industry.

“Real-world evidence is more critical than ever when it comes to making decisions for personalized patient care and precision medicine,” said Dr. Brigham Hyde, CEO and Co-Founder of Atropos Health. “Physicians and researchers rely on our solutions to generate new evidence from real-world clinical settings when those answers don't exist in published literature. We’re honored to be recognized by Fierce Healthcare and remain focused on closing the evidence gap and advancing the delivery of data-driven care.”

Atropos Health advances the use of real-world evidence (RWE) to help health systems and life science companies close critical evidence gaps in medicine and accelerate drug discovery and development. ChatRWD®, the first healthcare-specific large language model purpose-built to query real-world clinical data at scale, answers clinical questions rapidly with evidence, enabling faster, more informed decision-making for clinicians and researchers. Building on this momentum, the company recently introduced a Commercial Analytics solution for life sciences organizations and the Atropos Evidence™ Agent, an expert RWE agent for healthcare that integrates within physician workflows.

"Over the past eight years, we have reviewed hundreds of private companies for potential inclusion in the 'Fierce 15' special report. The selection draws from diverse sectors across the industry, from primary care to health technology. Year after year, these honorees remind us that the future of healthcare is being built right now, and this special report is our way of showcasing their innovative work and honoring their impact," said Ayla Ellison, Editor-in-Chief, Fierce Life Sciences and Healthcare.

About Fierce Healthcare

Fierce Healthcare delivers healthcare news at the intersection of business and policy. Our journalists strive to bring our readers breaking industry news, exclusive interviews and thoughtfully-reported stories that offer a deeper insight on how changes in the industry impact their corner of the healthcare world. Our family includes Fierce Healthcare, Fierce Health Payer, Fierce Health Tech, Fierce Hospitals and Fierce Health Finance. Click here to subscribe to one or all of our newsletters.

About Atropos Health

Atropos Health is the developer of GENEVA OS®, the operating system for rapid healthcare evidence across a robust network of real-world data. Healthcare and life science organizations work with Atropos Health to close evidence gaps from bench to bedside, improve individual patient outcomes with data-driven care, and expedite research that advances the field of medicine. We aim to transform healthcare with timely, relevant, real-world evidence.

To learn more about Atropos Health, visit www.atroposhealth.com or connect through LinkedIn or X (Twitter).

Contacts

Media Contact
Evan Scarduffa
atropos@solcomms.co

Atropos Health


Release Versions

Contacts

Media Contact
Evan Scarduffa
atropos@solcomms.co

More News From Atropos Health

Atropos Health Announces Key New Hires to Scale High Quality Evidence Utilization in the Healthcare Ecosystem

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence (RWE), announced the addition of two new hires to the leadership team, including the company's first Chief Technology Officer and Chief Financial Officer. The addition of these two team members expands the companies’ domain knowledge across the healthcare ecosystem including telehealth, payers and big tech. To further enhance the company's mission to clos...

Atropos Health Named to the 2026 New York Digital Health 100

NEW YORK--(BUSINESS WIRE)--Atropos Health announced today that it has been named to the 2026 New York Digital Health 100 (DH100), an annual recognition honoring the most innovative and high-impact digital health startups in the New York region. Published by Digital Health New York (DHNY), the DH100 is released in conjunction with the 2026 New York Healthcare Innovation Report, which analyzes key investment trends, market dynamics, and opportunities shaping the digital health ecosystem. Now in i...

Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence (RWE), today announced the availability of Commercial Analytics solutions for life science leaders. This is an extension to the already growing number of solutions available to life science companies to accelerate decision making across the Real World Data, R&D, HEOR/Medical, and Brand use cases. The solution leverages the speed and accuracy of ChatRW...
Back to Newsroom